Phase 1 TAK-906 Single and Multiple Ascending Dose Study in Japanese Healthy Male Participants
NCT03237156
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
24
Enrollment
INDUSTRY
Sponsor class
Conditions
Japanese Healthy Adult Male Participants
Interventions
DRUG:
TAK-906
DRUG:
TAK-906 Placebo
Sponsor
Takeda